Pretreatment of plantar warts with azone enhances the effect of 5-aminolevulinic acid photodynamic therapy

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 25, Issue 1-2, 2006, Pages 403-409

  Ziólkowski, Piotr ^a   Osiecka, Beata J ^a   Siewiński, MacIej ^a   Bronowicz, Andrzej ^a   Ziólkowska, Jolanta ^a   Gerber Leszczyszyn, Hanna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

5 aminolevulinic acid; Azone; Mosaic warts; Myrmecia; Photodynamic therapy; Plantar warts

Indexed keywords

AMINOLEVULINIC ACID; FLUOROURACIL; INTERFERON; LAUROCAPRAM; SALICYLIC ACID; UREA;

ADOLESCENT; ADULT; ARTICLE; BURN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG PENETRATION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 1; HYPERPIGMENTATION; INTERMETHOD COMPARISON; MALE; MOSAIC VIRUS; PAIN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PRURITUS; SCAR FORMATION; SKIN PENETRATION; VERRUCA PLANTARIS; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS TYPES;

EID: 33644752986     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.250     Document Type: Article

References (23)

1. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B:Biol 1990; 6:143-148.
2. Bolsen K, Lang K, Verwohlt B, Fritsch C, Goerz G. In vitro induction of porphyrin biosynthesis in various human cells after incubation with 5-aminolevulinic acid. Arch Dermatol Res 1996; 288:320A.
3. Malik Z, Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer 1987; 56:589-595.
4. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. A review. Arch Dermatol 1998; 134:207-214.
5. Fritsch C, Batz J, Bolsen K, Schulte KW, Zumdick M, Ruzicka T, Goerz G. Ex vivo application of 5-aminolevulinic acid induced high and specific porphyrin levels in human skin tumors: possible basis for selective photodynamic therapy. Photochem Photobiol 1997; 66:114-118.
6. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical 5-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors. J PhotochemPhotobiol B:Biol 1995;29: 53-57.
7. Lang K, Bolsen K, Stahl W, Ruzicka T, Sies H, Lehmann P, Fritsch C. The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin. J Photochem Photobiol B:Biol 2001; 65:29-34.
8. Tochiki M, Kawashima M, Ishiguro N, Minami H, Matsukura T. Typical and atypical cases of myrmecia - the differences in the nature of the inclusion bodies and the associated human papillomavirus types. Nippon Hif Gak Zass 1989; 99:593-599.
9. Kashima M, Adachi M, Honda M, Niimura M, Nakabayashi Y. A case of peculiar plantar warts. Human papillomavirus type 60 infection. Arch Dermatol 1994; 130:1418-1420.
10. Fabbrocini G, Di Costanzo MP, Riccardo AM, Quarto M, Colasanti A, Roberti G, Monfrecola G. Photodynamic therapy with topical delta-aminolaevulinic acid for the treatment of plantar warts. J Photochem Photobiol B:Biol 2001; 61:30-34.
11. Ma L, Moan J, Peng Q, Iani V. Production of protoporphyrin IX induced by 5-aminolevulinic acid in transplanted human colon adenocarcinoma of nude mice can be increased by ultrasound. Int J Cancer 1998; 78:464-469.
12. Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Cancer Res 2001; 61:5824-5832.
13. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001; 52:103-112.
14. Chuckler F, Lee G. Relating the concentration-dependent action of azone and dodecyl-L-pyroglutamate on the structure of excised human stratum corneum to changes in drug diffusivity, partition coefficient and flux. Int J Pharm 1992; 80:81-89.
15. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002; 146:178-188.
16. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, Langmack K, McKenna K, Moseley H, Pearse AD, Stringer M, Taylor DK, Wong G, Rhodes LE. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146:552-567.
17. Zamiri M, Gupta G. Plantar warts treated with an immune response modifier: a report of two cases. Clin Exp Dermatol. 2003; 28(suppl 1):45-47.
18. Ammann R, Hunziker T, Braathen LR. Topical photodynamic therapy in verrucae. A pilot study. Dermatology 1995; 191:346-347.
19. Ziólkowski P, Osiecka BJ, Oremek GM, Siewiński M, Symonowicz K, Saleh Y, Bronowicz A. Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. J Exp Ther Oncol 2004; 4:121-129.
20. Stender IM, Wulf CH. Treatment of recalcitrant verrucae by photosensitivity with topical application of delta-aminolaevulinic acid. Clin Exp Dermatol 1996; 21:390.
21. Stender IM, Lock-Anderson J, Wulf HC. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study. Clin Exp Dermatol 1999; 24:154-159.
22. Stender IM, Wulf HC. Photodynamic therapy of recalcitrant warts with 5-aminolaevulinic acid: a retrospective analysis. Acta Derm Venereol (Stockh) 1999; 79:400-401.
23. Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomized double-blind trial. Lancet 2000; 355:963-966.